Conn. Jumps Into Zyprexa Fray With Lawsuit

By Brendan Pierson

Law360, New York (March 07, 2008, 12:00 AM ET) -- Eli Lilly & Co. was hit with a new lawsuit Thursday over its controversial anti-psychotic drug Zyprexa, this time filed by the state of Connecticut.

Echoing allegations that Eli Lilly already faces in a massive multidistrict litigation in the Eastern District of New York, Connecticut alleges that Eli Lilly first overcharged for the drug and then marketed it through a fraudulent campaign that concealed its possible link to diabetes.

The lawsuit also alleges that the company engaged in racketeering with medical marketing firms and doctors in...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles